Fund Holdings — ACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value:
$129.59M
Total Bought:
$34.05M
Total Sold:
$20.65M
Net Transaction:
+$13.40M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Praxis Precision Medicines, Inc.(PRAX)82,79684,193+1,397$27.72M$24.52M18.92%-$3.20M
Whitehawk Therapeutics Inc4,685,9124,685,9120$21.46M$17.62M13.60%-$3.84M
Tango Therapeutics, Inc.(TNGX)390,949409,529+18,580$12.22M$10.22M7.88%-$2.00M
4d Molecular Therapeutics In507,801535,109+27,308$6.75M$7.66M5.91%+$903.7K
argenx SEADR(ARGX)4,7055,558+853$4.37M$5.33M4.11%+$964.5K
Arrivent Biopharma Inc218,694170,893-47,801$7.60M$5.17M3.99%-$2.42M
Surrozen Inc173,395152,541-20,854$4.50M$4.91M3.79%+$409.2K
Vogenx Inc0213,186+213,186$0$4.86M3.75%+$4.86M
Bright Minds Biosciences Inc92,74593,152+407$6.51M$4.64M3.58%-$1.87M
Ocular Therapeutix, Inc.(OCUL)532,481574,543+42,062$5.23M$4.41M3.40%-$822.2K
Silence Therapeutics plcADS(SLN)0393,583+393,583$0$4.30M3.32%+$4.30M
Taysha Gene Therapies, Inc.(TSHA)561,808691,843+130,035$3.83M$3.37M2.60%-$456.6K
Avalyn Pharma Inc115,000114,749-251$3.79M$3.27M2.52%-$516.6K
Avalo Therapeutics Inc186,308186,3080$3.44M$2.86M2.20%-$586.9K
MoonLake ImmunotherapeuticsCLASS ORD A(MLTX)215,652216,568+916$4.20M$2.53M1.96%-$1.66M
Opus Genetics Inc0514,110+514,110$0$2.49M1.92%+$2.49M
Minerva Neurosciences709,500729,500+20,000$3.94M$2.44M1.89%-$1.49M
LB Pharmaceuticals Inc(LBRX)28,91952,718+23,799$938.6K$2.02M1.56%+$1.08M
Artiva Biotherapeutics Inc260,416260,4160$2.53M$1.85M1.43%-$671.9K
Amylyx Pharmaceuticals, Inc.(AMLX)168,11562,956-105,159$3.02M$1.83M1.41%-$1.19M
Revolution Medicines, Inc.(RVMD)08,237+8,237$0$1.69M1.30%+$1.69M
Irulya Therapeutics Inc052,918+52,918$0$1.64M1.27%+$1.64M
Roivant Sciences Ltd.SHS(ROIV)041,535+41,535$0$1.52M1.17%+$1.52M
Design Therapeutics Inc282,564115,392-167,172$4.09M$1.45M1.12%-$2.64M
United Therapeutics Corporation(UTHR)2,2242,240+16$1.21M$1.21M0.94%+$8.8K
Contineum Therapeutics Inc-ACL A63,09589,826+26,731$1.03M$1.21M0.93%+$171.3K
Oric Pharmaceuticals Inc087,918+87,918$0$1.18M0.91%+$1.18M
Erasca, Inc.(ERAS)265,19967,541-197,658$4.86M$990.2K0.76%-$3.87M
An2 Therapeutics Inc0142,051+142,051$0$755.7K0.58%+$755.7K
Adial Pharmaceuticals Inc0129,982+129,982$0$521.2K0.40%+$521.2K
Sutro Biopharma Inc270,25125,290-244,961$8.97M$407.4K0.31%-$8.56M
Equillium Inc0183,000+183,000$0$297.4K0.23%+$297.4K
Compass Therapeutics Inc595,213251,001-344,212$1.30M$261.0K0.20%-$1.04M
Stoke Therapeutics, Inc.(STOK)05,771+5,771$0$150.0K0.12%+$150.0K
Page 1 of 1
ACUTA CAPITAL PARTNERS, LLC — 13F Holdings — Q3 2026 | TickerTrail